Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.26
+0.15 (0.99%)
Apr 29, 2026, 11:29 AM CST
Tasly Pharmaceutical Group Company Description
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China.
The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs.
It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012.
Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Tasly Pharmaceutical Group Co., Ltd
| Country | China |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 10,563 |
| CEO | Jin Yong Cai |
Contact Details
Address: No. 2 Pujihe East Road Tianjin, 300410 China | |
| Phone | 86 22 2673 6999 |
| Website | taslypharma.com |
Stock Details
| Ticker Symbol | 600535 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001C81 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jin Yong Cai | GM and Director |
| Jie Wei | Chief Financial Officer and Head of Accounting |
| Yu Jie | Secretary and Vice President |
| Shunnan Zhang | Deputy GM and Supervisor |